Russian Sovereign Wealth Fund Says "Sputnik 5" COVID Vaccine Is 95% Effective

Tyler Durden's Photo
by Tyler Durden
Tuesday, Nov 24, 2020 - 08:33 AM

Update (0800ET): Apparently, Russia is taking a page out of the Pfizer playbook as the final data released by the government regarding the efficacy of Sputnik 5 shows that the vaccine is actually 95% effective, not the 91%-92% reported earlier.

Russian authorities also claimed their vaccine had greater efficacy than the Oxford-AstraZeneca vaccine because of Russia’s proprietary technology. The two vaccines both rely on the adenovirus-vector technique, though each follows its own procedure.

"Sputnik shows very high effectiveness, higher than 95%," Kirill Dmitriev, the head of the Russian Direct Investment Fund, said on Tuesday. "This is indisputably positive news not just for Russia, but for the entire world, for all countries."

The preliminary results were released as competition heats up among vaccine developers to mass produce a coronavirus jab and try to bring about an end to the pandemic.

* * *

Russia has two coronavirus vaccine projects that are in the final stages of development (one of which infamously became the first vaccine to receive the approval of state regulators back in August), but despite the fact that many Russians (including, reportedly, one of the president's adult daughters) were given the option of receiving the experimental vaccines, President Vladimir Putin has yet to be vaccinated.

Putin's spokesman Dmitry Peskov said Tuesday that Putin wouldn't be eligible to take an experimental vaccine since, as the head of state, that would be against the rules.

"We have not yet begun widespread vaccination and the head of state can’t take part in vaccination as a volunteer. It’s impossible," Kremlin spokesman Dmitry Peskov told reporters Tuesday. "The president can’t use an uncertified vaccine."

Apparently, the question of whether or not Putin had been vaccinated had become a major issue in the Russian press. To be sure, 68-year-old Putin is in a higher risk category due to his age. But the president is also known to keep up a demanding fitness routine that includes Judo training.

According to TASS, one of Russia's state-run newswires, the first group of volunteers aged 60 and older only just began trials on Oct. 28, according to the doctor who is supervising the tests.

In mid-October, roughly two months after Russia's first vaccine was approved, Russian health authorities approved a second COVID-19 vaccine, this one created by a former biological weapons research laboratory, the Vector State Virology and Biotechnology Center in Siberia.

Putin said during televised comments at the time: “We need to increase production of our first and now our second vaccine...First of all we should supply the domestic market.”

Russia has also made deals with international partners to share its vaccine. "Sputnik V" will cost less than $20 - half the price of the Moderna vaccine and also less than Pfizer's - in international markets for a two-shot course of treatment, making it one of the cheapest options on the market.

After preliminary results purported to show Russia's "Sputnik 5" vaccine to be 92% effective, final results released Tuesday that initial testing showed it was 91% effective in preventing infections, although it has not yet published final results in a peer-reviewed journal. Russia has already started vaccinating teachers, health-care workers and other high-risk individuals as the brutal Russian winter ushers in a resurgence of the virus. Russia has the fifth-highest tally of confirmed virus cases, but one of the lowest per-capita mortality rates (though many believe Russia is suppressing the true number of COVID-related deaths).